The D-1 agonist SKF 38393 (2 mg/kg s.c.) failed to induce contralateral turning in drug-naive rats, lesioned unilaterally with 6-hydroxydopamine (6-OHDA) from 17 days, while elicited intense contralateral turning 90 days post lesion. Priming with a single administration of a dopaminergic (DA) agonist which elicited contralateral turning by itself, made SKF 38393 very active in producing contralateral turning in rats, lesioned with 6-OHDA from 17 days. The effectiveness of the D-1/D-2 agonist apomorphine as a primer of SKF 39393 induced turning was critically dependent on the interval between the administration of the two agonists. Effectiveness was minimal with an interval of 3 h, increased after 6–12 h, peaking at 72 h and was reduced afte...
In rats with a unilateral 6-hydroxydopamine lesion of the ascending dopamine neurons, we investigate...
Dopamine (DA) and glutamate N-methyl-d-aspartate (NMDA) receptors extensively interact in the mediat...
In rats with unilateral 6-hydroxydopamine (6-OHDA) lesions of the nigrostriatal dopaminergic pathway...
The D-1 agonist SKF 38393 (2 mg/kg s.c.) failed to induce contralateral turning in drug-naive rats, ...
The D-1 receptor agonist, SKF 38393 (2 mg/kg s.c.), failed to elicit contralateral turning when admi...
In adult rats bearing unilateral 6-hydroxydopamine (6-OHDA) lesions of the ascending dopaminergic ne...
Previous exposure to a dopaminergic agonist (priming) strongly potentiates contralateral turning beh...
SKF 38393 (2 mg/kg s.c.), a reportedly selective D-1 agonist, failed to induce contralateral turning...
he D1 agonist, SKF 38393, failed to induce contralateral turning in drug-naive rats lesioned unilate...
Repetitive stimulation of dopamine receptors located in the basal ganglia may lead to the manifestat...
In rats unilaterally lesioned with 6-hydroxydopamine, the D-1 agonist SKF 38393 (3 mg/kg SC) induced...
The D1 agonist, SKF 38393, failed to induce contralateral turning in drug-naive rats lesioned unilat...
A low dose of the D-1 receptor agonist SKF 38393 (2.0 mg/kg s.c.) 14 days post-lesion failed to indu...
In rats with unilateral lesion of the nigrostriatal dopaminergic pathway, L-DOPA induces contralater...
The non competitive antagonist of N-methyl-D-aspartate (NMDA) receptors MK-801, at doses which did n...
In rats with a unilateral 6-hydroxydopamine lesion of the ascending dopamine neurons, we investigate...
Dopamine (DA) and glutamate N-methyl-d-aspartate (NMDA) receptors extensively interact in the mediat...
In rats with unilateral 6-hydroxydopamine (6-OHDA) lesions of the nigrostriatal dopaminergic pathway...
The D-1 agonist SKF 38393 (2 mg/kg s.c.) failed to induce contralateral turning in drug-naive rats, ...
The D-1 receptor agonist, SKF 38393 (2 mg/kg s.c.), failed to elicit contralateral turning when admi...
In adult rats bearing unilateral 6-hydroxydopamine (6-OHDA) lesions of the ascending dopaminergic ne...
Previous exposure to a dopaminergic agonist (priming) strongly potentiates contralateral turning beh...
SKF 38393 (2 mg/kg s.c.), a reportedly selective D-1 agonist, failed to induce contralateral turning...
he D1 agonist, SKF 38393, failed to induce contralateral turning in drug-naive rats lesioned unilate...
Repetitive stimulation of dopamine receptors located in the basal ganglia may lead to the manifestat...
In rats unilaterally lesioned with 6-hydroxydopamine, the D-1 agonist SKF 38393 (3 mg/kg SC) induced...
The D1 agonist, SKF 38393, failed to induce contralateral turning in drug-naive rats lesioned unilat...
A low dose of the D-1 receptor agonist SKF 38393 (2.0 mg/kg s.c.) 14 days post-lesion failed to indu...
In rats with unilateral lesion of the nigrostriatal dopaminergic pathway, L-DOPA induces contralater...
The non competitive antagonist of N-methyl-D-aspartate (NMDA) receptors MK-801, at doses which did n...
In rats with a unilateral 6-hydroxydopamine lesion of the ascending dopamine neurons, we investigate...
Dopamine (DA) and glutamate N-methyl-d-aspartate (NMDA) receptors extensively interact in the mediat...
In rats with unilateral 6-hydroxydopamine (6-OHDA) lesions of the nigrostriatal dopaminergic pathway...